Brief: Iovance Biotherapeutics Q2 Net Income USD -97.101 Million
08/08/2024 21:02
Aug 08 (Reuters) - Iovance Biotherapeutics Q2 pretax profit USD -98.559 million. * Q2 operating income USD -101.914 million
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies